Dexcom (DXCM) Cash from Investing Activities (2010 - 2026)

Dexcom (DXCM) has 17 years of Cash from Investing Activities data on file, last reported at -$298.5 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 397.9% year-over-year to -$298.5 million in Q1 2026; TTM through Mar 2026 was $137.3 million, a 175.4% increase from a year earlier, with the FY2025 full-year figure at $536.0 million, up 358.31% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$298.5 million, down from $306.6 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for DXCM reached as high as $414.9 million in Q4 2023 and fell as low as -$555.9 million in Q2 2023.
• Historically, Cash from Investing Activities has averaged -$58.7 million across 5 years, with a median of -$144.9 million in 2022.
• Across the five-year window, Cash from Investing Activities soared 690.69% in 2022 and tumbled 397.9% in 2026, its largest moves.
• Year by year, Cash from Investing Activities stood at -$194.1 million in 2022, then surged by 313.76% to $414.9 million in 2023, then plunged by 173.2% to -$303.7 million in 2024, then jumped by 200.95% to $306.6 million in 2025, then sank by 197.36% to -$298.5 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$298.5 million in Q1 2026, $306.6 million in Q4 2025, and $192.8 million in Q3 2025.